CC BY-NC-ND 4.0 · Journal of Coloproctology 2022; 42(01): 025-031
DOI: 10.1055/s-0041-1736517
Original Article

Diagnosis of Advanced Disease in Cases of Colorectal Cancer in a Developing Country

1   Hospital Universitário Lauro Wanderley, Unidade de Laboratório de Anatomia Patológica, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil
,
2   Faculdade de Medicina, Centro Universitário de João Pessoa, João Pessoa, Paraíba, Brazil
,
3   Faculdade de Medicina, Departamento de Patologia, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
,
3   Faculdade de Medicina, Departamento de Patologia, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
› Author Affiliations

Abstract

Objectives Colorectal cancer (CRC) is the second leading cause of cancer death in the world, with survival correlated with the extension of the disease at diagnosis. In many low-/middle-income countries, the incidence of CRC is increasing rapidly, while decreasing rates are observed in high-income countries. We evaluated the anatomopathological profile of 390 patients diagnosed with CRC who underwent surgical resection, over a six-year period, in the state of Paraíba, northeastern Brazil.

Results Adenocarcinomas accounted for 98% of the cases of primary colorectal tumors, and 53.8% occurred in female patients. The average age of the sample was 63.5 years, with 81.8% of individuals older than 50 years of age and 6.4% under 40 years of age. The most frequent location was the distal colon; pT3 status was found in 71% of patients, and pT4 status, in 14.4%. Angiolymphatic and lymph-node involvements were found in 48.7% and 46.9% of the cases respectively. Distant metastasis was observed in 9.2% of the patients. Advanced disease was diagnosed in almost half of the patients (48.1%). The women in the sample had poorly-differentiated adenocarcinomas (p = 0.043). Patients under 60 years of age had a higher rate of lymph-node metastasis (p = 0.044). Tumor budding was present in 27.2% of the cases, and it was associated with the female gender, the mucinous histological type, and the depth of invasion (pT3 and pT4).

Conclusions We conclude that the diagnosis of advanced disease in CRC is still a reality, with a high occurrence of aggressive prognostic factors, which results in a worse prognosis.



Publication History

Received: 02 April 2021

Accepted: 15 June 2021

Article published online:
18 November 2021

© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Siegel RL, Miller KD, Goding Sauer A. et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020; 70 (03) 145-164
  • 2 Nagtegaal ID, Odze RD, Klimstra D. et al; WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76 (02) 182-188
  • 3 González N, Prieto I, Del Puerto-Nevado L. et al; DiabetesCancerConnect Consortium. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 2017; 8 (11) 18456-18485
  • 4 Pestana JSG, Martins SFF. Colorectal cancer: comparative analysis of clinical and pathological characteristics in patients aged above and below 45 years of age and impact on prognosis. J Coloproctol (Rio J) 2016; 36 (04) 196-202
  • 5 Karamchandani DM, Chetty R, King TS. et al. Challenges with colorectal cancer staging: results of an international study. Mod Pathol 2020; 33 (01) 153-163
  • 6 Araghi M, Soerjomataram I, Jenkins M. et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144 (12) 2992-3000
  • 7 Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality. Clin Colorectal Cancer 2016; 15 (03) 195-203
  • 8 Santos Mde O. Estimativa/2020–Incidência de Câncer no Brasil. Rev Bras Cancerol 2020; 66 (01) e00927
  • 9 Leung WK, Chen W-Q, Gu L, Long D, Law WL. Distributions of colorectal cancer in two Chinese cities with contrasting colorectal cancer epidemiology. J Gastroenterol Hepatol 2015; 30 (12) 1726-1730
  • 10 Lee DH, Keum N, Giovannucci EL. Colorectal Cancer Epidemiology in the Nurses' Health Study. Am J Public Health 2016; 106 (09) 1599-1607
  • 11 Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 2019; 14 (02) 89-103
  • 12 Glover M, Mansoor E, Panhwar M, Parasa S, Cooper GS. Epidemiology of Colorectal Cancer in Average Risk Adults 20-39 Years of Age: A Population-Based National Study. Dig Dis Sci 2019; 64 (12) 3602-3609
  • 13 Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet 2016; 7 (03) 105-114
  • 14 Mesker WE, Junggeburt JMC, Szuhai K. et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 2007; 29 (05) 387-398
  • 15 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383 (9927): 1490-1502
  • 16 Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol 2017; 116 (08) 969-982
  • 17 Pereira Júnior T, Alves AJ, Nogueira AMMF. Câncer colorretal: análise anatomopatológica de 476 colectomias consecutivas em Belo Horizonte (MG). J Bras Patol Med Lab 2005; 41 (03) 175-184
  • 18 Volpato MG, Koch Kde S. Fatores de mau prognóstico nas peças operatórias de pacientes submetidos ao tratamento cirúrgico do câncer colorretal. Rev Bras Coloproctol 2008; 28 (04) 414-424
  • 19 Amin MB. American Joint Committee on Cancer, American Cancer Society. editors. AJCC cancer staging manual. Eight edition / editor-in-chief, Mahul B. Amin, MD, FCAP; editors, Stephen B. Edge, MD, FACS [and 16 others]; Donna M. Gress, RHIT, CTR-Technical editor; Laura R. Meyer, CAPM-Managing editor. Chicago IL: American Joint Committee on Cancer, Springer; 2017
  • 20 Santos Mde O. Estimativa 2018: Incidência de Câncer no Brasil. Rev Bras Cancerol 2018; 64 (01) 119-120
  • 21 Gasparini B, Valadão M, Miranda-Filho A, Silva CMFPD. [Analysis of the age-period-cohort effect on mortality from colorectal cancer in Rio de Janeiro State, Brazil, from 1980 to 2014]. Cad Saude Publica 2018; 34 (03) e00038017
  • 22 Saad-Hossne R, Prado RG, Bakonyi Neto A. et al. Estudo retrospectivo de pacientes portadores de câncer colorretal atendidos na Faculdade de Medicina de Botucatu no período de 2000-2003. Rev Bras Coloproctol 2005; 25 (01) 31-37
  • 23 Pescatore P, Scheiden R, Abeywickrama KH, Braun M, Capesius C. Evolution of colorectal cancer epidemiology in a setting of opportunistic screening. A 20 year national survey in Luxembourg. Acta Gastroenterol Belg 2013; 76 (01) 25-33
  • 24 Valadão M, Leal RA, Barbosa LC, Carneiro M, Muharre RJ. Perfil dos pacientes portadores de câncer colorretal operados em um hospital geral: necessitamos de um programa de rastreamento acessível e efetivo. Rev Bras Coloproctol. 2010; 30 (02) 160-166
  • 25 Cserni G. Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 2003; 56 (05) 327-335
  • 26 Bowel cancer statistics [Internet]. Cancer Research UK. 2017 [cited 2020 Oct 27]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer
  • 27 Lugli A, Kirsch R, Ajioka Y. et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 2017; 30 (09) 1299-1311
  • 28 Wang W, Chen W, Lin J, Shen Q, Zhou X, Lin C. Incidence and characteristics of young-onset colorectal cancer in the United States: An analysis of SEER data collected from 1988 to 2013. Clin Res Hepatol Gastroenterol 2019; 43 (02) 208-215
  • 29 Valle L, Vilar E, Tavtigian SV, Stoffel EM. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol 2019; 247 (05) 574-588
  • 30 Siegel RL, Miller KD, Fedewa SA. et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67 (03) 177-193
  • 31 de Oliveira MM, Latorre M, Tanaka LF, Rossi BM, Curado MP. Disparidades na mortalidade de câncer colorretal nos estados brasileiros. Rev Bras Epidemiol. 2018; 21: e180012
  • 32 de Andrade Pullig E, Garcia Cunha Lopes G, Porto Magalhães Netto G, Moreira Ribeiro J, Amorim Silva L, Lima De Moraes Morué N. Câncer colorretal no Brasil: aspectos topográficos e epidemiológicos (2000-2011). 2019 Jul [cited 2021 May 27]; Available from: http://repositorio.aee.edu.br/jspui/handle/aee/1365